Outcome Studies

EAB has completed successful community-based, randomized outcome studies on fibromyalgia (FM), chronic fatigue (CFIDS), and Type 1 & 2 diabetes, proving the validity and reliability of the LRA program.

"A Novel Treatment for Fibromyalgia Improves Clinical Outcomes in a Community-Based Study" read more

• 50% less pain
• 70% less depression
• 50% more energy
• 30% less stiffness

"Tolerance loss in diabetics: Link with foreign antigen exposure." read more

• >1 mg/dl decrease in Hgb A1c levels in both Type 2 & Type 1 diabetes
• 18% reduction of insulin levels in Type 2 diabetes